These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30078300)

  • 21. Law enforcement and drug treatment: a culture clash.
    Cohen J
    Science; 2010 Jul; 329(5988):169. PubMed ID: 20616266
    [No Abstract]   [Full Text] [Related]  

  • 22. Policing and risk of overdose mortality in urban neighborhoods.
    Bohnert AS; Nandi A; Tracy M; Cerdá M; Tardiff KJ; Vlahov D; Galea S
    Drug Alcohol Depend; 2011 Jan; 113(1):62-8. PubMed ID: 20727684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examining the spatial distribution of law enforcement encounters among people who inject drugs after implementation of Mexico's drug policy reform.
    Gaines TL; Beletsky L; Arredondo J; Werb D; Rangel G; Vera A; Brouwer K
    J Urban Health; 2015 Apr; 92(2):338-51. PubMed ID: 25300503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Policing, massive street drug testing and poly-substance use chaos in Georgia - a policy case study.
    Otiashvili D; Tabatadze M; Balanchivadze N; Kirtadze I
    Subst Abuse Treat Prev Policy; 2016 Jan; 11():4. PubMed ID: 26772817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?
    Degenhardt L; Day C; Hall W; Conroy E; Gilmour S
    BMC Public Health; 2005 Apr; 5():40. PubMed ID: 15840173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring improvement in knowledge of drug policy reforms following a police education program in Tijuana, Mexico.
    Arredondo J; Strathdee SA; Cepeda J; Abramovitz D; Artamonova I; Clairgue E; Bustamante E; Mittal ML; Rocha T; Bañuelos A; Olivarria HO; Morales M; Rangel G; Magis C; Beletsky L
    Harm Reduct J; 2017 Nov; 14(1):72. PubMed ID: 29117858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV, drugs and the legal environment.
    Strathdee SA; Beletsky L; Kerr T
    Int J Drug Policy; 2015 Feb; 26 Suppl 1(0 1):S27-32. PubMed ID: 25265900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ups and downs of addiction harm reduction in Iran: key insights and implications for harm reduction policy and policing.
    Shafiee SA; Vedadhir A; Razaghi E
    Harm Reduct J; 2023 Jan; 20(1):8. PubMed ID: 36670386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Crisis in Our Neighborhood.
    Bitterman J
    AMA J Ethics; 2018 Feb; 20(1):195-196. PubMed ID: 29460773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks.
    Hyshka E; Anderson-Baron J; Karekezi K; Belle-Isle L; Elliott R; Pauly B; Strike C; Asbridge M; Dell C; McBride K; Hathaway A; Wild TC
    Harm Reduct J; 2017 Jul; 14(1):50. PubMed ID: 28747183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Training law enforcement to respond to opioid overdose with naloxone: Impact on knowledge, attitudes, and interactions with community members.
    Wagner KD; Bovet LJ; Haynes B; Joshua A; Davidson PJ
    Drug Alcohol Depend; 2016 Aug; 165():22-8. PubMed ID: 27262898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation contexts and the impact of policing on access to supervised consumption services in Toronto, Canada: a qualitative comparative analysis.
    Bardwell G; Strike C; Altenberg J; Barnaby L; Kerr T
    Harm Reduct J; 2019 May; 16(1):30. PubMed ID: 31046759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-threshold methadone treatment, heroin price, police activity and incidence of heroin use: the Zurich experience.
    Nordt C; Stohler R
    Int J Drug Policy; 2009 Nov; 20(6):497-501. PubMed ID: 19349154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A scoping review of harm reduction training for police officers.
    Khorasheh T; Naraine R; Watson TM; Wright A; Kallio N; Strike C
    Drug Alcohol Rev; 2019 Feb; 38(2):131-150. PubMed ID: 30785229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Harm reduction interventions in drug users: current situation and recommendations].
    Bosque-Prous M; Brugal MT
    Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-related police encounters across the globe: How do they compare?
    Hughes CE; Barratt MJ; Ferris JA; Maier LJ; Winstock AR
    Int J Drug Policy; 2018 Jun; 56():197-207. PubMed ID: 29699837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Spatial-Temporal Pattern of Policing Following a Drug Policy Reform: Triangulating Self-Reported Arrests With Official Crime Statistics.
    Gaines TL; Werb D; Arredondo J; Alaniz VM; Vilalta C; Beletsky L
    Subst Use Misuse; 2017 Jan; 52(2):214-222. PubMed ID: 27767367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.
    Calvo M; MacFarlane J; Zaccaro H; Curtis M; Cabán M; Favaro J; Passannante MR; Frost T
    Drug Alcohol Depend; 2017 Sep; 178():106-114. PubMed ID: 28645060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy.
    Faulkner-Gurstein R
    Soc Sci Med; 2017 May; 180():20-27. PubMed ID: 28315595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.